ARTICLE | Company News
Evotec acquiring Aptuit
July 31, 2017 10:51 PM UTC
Evotec AG (Xetra:EVT) is acquiring fellow drug discovery services company Aptuit LLC (Greenwich, Conn) for $300 million. Evotec said it would finance the acquisition, which is expected to close in 3Q17, through a €140 million ($164 million) debt facility and with cash on hand.
Evotec gains 750 employees and manufacturing sites in Verona, Italy; Basel, Switzerland; and Oxford, U.K. Evotec said that Aptuit reported 2016 revenues of €88 million ($92.5 million); Evotec reported €164.5 million ($173 million) over the same period...